We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Bristol-Myers Squibb to Acquire Padlock Therapeutics

News   Mar 24, 2016

 
Bristol-Myers Squibb to Acquire Padlock Therapeutics
 
 
Advertisement
 

RELATED ARTICLES

Study Indicates a Lack of Diversity in COVID-19 Clinical Trials

News

Despite disproportionately higher rates of COVID-19 infection, hospitalization and death among people of color, minority groups are significantly underrepresented in COVID-19 clinical trials, according to a new study.

READ MORE

Immune System Deviations Revealed in Severe COVID-19 Cases

News

A study has turned up immunological deviations and lapses that appear to spell the difference between severe and mild cases of COVID-19.

READ MORE

New Molecule Suppresses Inflammatory Process in Mice With Genetically-Induced Arthritis

News

A new molecule, developed in the laboratory, has been shown to have potential therapeutic effects. The drug was tested in mice with genetically-induced arthritis, it suppressed the inflammatory process, reducing inflammation and joint tissue wear and tear.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE